Literature DB >> 10197819

Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles.

L M Callahan1, W A Vaules, P D Coleman.   

Abstract

Combining immunocytochemistry with in situ hybridization of Alzheimer disease (AD) hippocampus demonstrated a 50% reduction in grain density for synaptophysin message over CA1 pyramidal neurons containing neurofibrillary tangles (NFT) relative to near neighbor NFT-free neurons. This decrease was not global, but was selective since message grain density for the lysosomal protein, cathepsin D, increased 33% in these neurons (relative to NFT-free neurons). Poly A+ message grain density decreased by 25% in NFT neurons. Percent of the cell body containing NFT correlated -0.35 (p < 0.0001) with grain density for synaptophysin message. These data verify the concept of altered profiles of gene expression as a function of disease state within single cells and suggest that events associated with NFT formation may lead to altered expression of synaptic messages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197819     DOI: 10.1097/00005072-199903000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  48 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

3.  Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

Authors:  Melissa J Alldred; Karen E Duff; Stephen D Ginsberg
Journal:  Neurobiol Dis       Date:  2011-11-07       Impact factor: 5.996

Review 4.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

5.  Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.

Authors:  Ben A Bahr; Meagan L Wisniewski; David Butler
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

Review 6.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

7.  Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.

Authors:  Shaowu Cheng; Willayat Y Wani; David A Hottman; Angela Jeong; Dongfeng Cao; Kyle J LeBlanc; Paul Saftig; Jianhua Zhang; Ling Li
Journal:  J Neurochem       Date:  2017-05-26       Impact factor: 5.372

8.  Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.

Authors:  Kishore Viswanathan; Dennis J Hoover; Jeannie Hwang; Meagan L Wisniewski; Uzoma S Ikonne; Ben A Bahr; Dennis L Wright
Journal:  ACS Med Chem Lett       Date:  2012-09-09       Impact factor: 4.345

Review 9.  Lysosomal enzymes, cathepsins in brain tumour invasion.

Authors:  Natasa Levicar; Tadej Strojnik; Janko Kos; Ricardo A Dewey; Geoffrey J Pilkington; Tamara T Lah
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

10.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.